

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.66260781 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.51672490 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.42824875 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.42824875 |
| 5 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.12007478 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.86194474 |
| 7 | leukocyte aggregation (GO:0070486) | 4.76910444 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.58821599 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 4.58821599 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.58821599 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.58821599 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.58821599 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.58821599 |
| 14 | detection of other organism (GO:0098543) | 4.48034398 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.25486442 |
| 16 | detection of bacterium (GO:0016045) | 4.23631150 |
| 17 | negative thymic T cell selection (GO:0045060) | 4.15572500 |
| 18 | immunoglobulin mediated immune response (GO:0016064) | 4.13035836 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 4.11856138 |
| 20 | negative T cell selection (GO:0043383) | 4.06112395 |
| 21 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.04579492 |
| 22 | negative regulation of cell killing (GO:0031342) | 4.03654281 |
| 23 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.03654281 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 3.95422817 |
| 25 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.94354660 |
| 26 | negative regulation of T cell mediated immunity (GO:0002710) | 3.91727599 |
| 27 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.91238294 |
| 28 | response to peptidoglycan (GO:0032494) | 3.90003638 |
| 29 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.89689468 |
| 30 | detection of external biotic stimulus (GO:0098581) | 3.88611084 |
| 31 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.86334874 |
| 32 | detection of molecule of bacterial origin (GO:0032490) | 3.86181186 |
| 33 | positive regulation of B cell differentiation (GO:0045579) | 3.84047786 |
| 34 | regulation of B cell differentiation (GO:0045577) | 3.82916312 |
| 35 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.80429049 |
| 36 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.76481919 |
| 37 | positive thymic T cell selection (GO:0045059) | 3.76132069 |
| 38 | respiratory burst (GO:0045730) | 3.72290696 |
| 39 | T cell migration (GO:0072678) | 3.71202990 |
| 40 | positive regulation of interferon-alpha production (GO:0032727) | 3.64998150 |
| 41 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.63902818 |
| 42 | B cell receptor signaling pathway (GO:0050853) | 3.62428826 |
| 43 | microglial cell activation (GO:0001774) | 3.53012921 |
| 44 | regulation of interferon-alpha production (GO:0032647) | 3.52701200 |
| 45 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.50896368 |
| 46 | response to interleukin-15 (GO:0070672) | 3.49106073 |
| 47 | cellular extravasation (GO:0045123) | 3.48502959 |
| 48 | tolerance induction (GO:0002507) | 3.47934629 |
| 49 | detection of biotic stimulus (GO:0009595) | 3.43530965 |
| 50 | interferon-gamma production (GO:0032609) | 3.43124119 |
| 51 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.42866413 |
| 52 | positive regulation of antigen processing and presentation (GO:0002579) | 3.39575160 |
| 53 | neutrophil activation (GO:0042119) | 3.39197692 |
| 54 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.37962042 |
| 55 | B cell mediated immunity (GO:0019724) | 3.34076604 |
| 56 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.33532268 |
| 57 | myeloid dendritic cell activation (GO:0001773) | 3.32080938 |
| 58 | regulation of mast cell degranulation (GO:0043304) | 3.26582500 |
| 59 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.25596186 |
| 60 | response to host immune response (GO:0052572) | 3.25596186 |
| 61 | positive regulation of mast cell activation (GO:0033005) | 3.25592280 |
| 62 | granulocyte activation (GO:0036230) | 3.25581539 |
| 63 | cellular response to interleukin-15 (GO:0071350) | 3.25133188 |
| 64 | thymic T cell selection (GO:0045061) | 3.23856813 |
| 65 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.23097605 |
| 66 | macrophage activation (GO:0042116) | 3.22732537 |
| 67 | defense response to protozoan (GO:0042832) | 3.22215743 |
| 68 | macrophage activation involved in immune response (GO:0002281) | 3.21852259 |
| 69 | mast cell activation (GO:0045576) | 3.19806845 |
| 70 | response to type I interferon (GO:0034340) | 3.17298359 |
| 71 | NIK/NF-kappaB signaling (GO:0038061) | 3.17043726 |
| 72 | myeloid dendritic cell differentiation (GO:0043011) | 3.16695026 |
| 73 | cellular response to type I interferon (GO:0071357) | 3.15905658 |
| 74 | type I interferon signaling pathway (GO:0060337) | 3.15905658 |
| 75 | leukocyte cell-cell adhesion (GO:0007159) | 3.14494274 |
| 76 | regulation of tolerance induction (GO:0002643) | 3.14257298 |
| 77 | myeloid cell activation involved in immune response (GO:0002275) | 3.13392246 |
| 78 | response to muramyl dipeptide (GO:0032495) | 3.13257738 |
| 79 | response to protozoan (GO:0001562) | 3.12117892 |
| 80 | negative regulation of interleukin-12 production (GO:0032695) | 3.11137547 |
| 81 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.09485676 |
| 82 | negative regulation of phagocytosis (GO:0050765) | 3.08880085 |
| 83 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.06356110 |
| 84 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.05496989 |
| 85 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.03376314 |
| 86 | T cell selection (GO:0045058) | 3.02443777 |
| 87 | positive regulation of isotype switching (GO:0045830) | 3.02197976 |
| 88 | regulation of mast cell activation (GO:0033003) | 3.01397008 |
| 89 | response to host (GO:0075136) | 3.00827146 |
| 90 | response to host defenses (GO:0052200) | 3.00827146 |
| 91 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.00827146 |
| 92 | cellular response to zinc ion (GO:0071294) | 3.00527409 |
| 93 | leukocyte degranulation (GO:0043299) | 2.99992612 |
| 94 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.99697031 |
| 95 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.99054553 |
| 96 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.98723488 |
| 97 | actin nucleation (GO:0045010) | 2.98636126 |
| 98 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.98541748 |
| 99 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.98448671 |
| 100 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.96965727 |
| 101 | positive T cell selection (GO:0043368) | 2.96320825 |
| 102 | positive regulation of interleukin-2 production (GO:0032743) | 2.95029140 |
| 103 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.93098787 |
| 104 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.93098787 |
| 105 | neutrophil mediated immunity (GO:0002446) | 2.91955831 |
| 106 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.91512698 |
| 107 | pinocytosis (GO:0006907) | 2.90823356 |
| 108 | regulation of antigen processing and presentation (GO:0002577) | 2.90322848 |
| 109 | activated T cell proliferation (GO:0050798) | 2.89815503 |
| 110 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.89804812 |
| 111 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.88724774 |
| 112 | regulation of T cell tolerance induction (GO:0002664) | 2.87718813 |
| 113 | T cell costimulation (GO:0031295) | 2.87327868 |
| 114 | positive regulation of granulocyte differentiation (GO:0030854) | 2.86392785 |
| 115 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.84975954 |
| 116 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.84412891 |
| 117 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.84303902 |
| 118 | positive regulation of B cell mediated immunity (GO:0002714) | 2.83496237 |
| 119 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.83496237 |
| 120 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.83218259 |
| 121 | lymphocyte costimulation (GO:0031294) | 2.82995089 |
| 122 | germinal center formation (GO:0002467) | 2.81649466 |
| 123 | positive regulation of humoral immune response (GO:0002922) | 2.79087766 |
| 124 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.78930119 |
| 125 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.76635113 |
| 126 | positive regulation of interferon-beta production (GO:0032728) | 2.73912427 |
| 127 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.72986444 |
| 128 | T cell proliferation (GO:0042098) | 2.72075702 |
| 129 | regulation of response to interferon-gamma (GO:0060330) | 2.71831483 |
| 130 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.71288428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.37019374 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.01346792 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.97829407 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.33397970 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.29953574 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.26895866 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.93365839 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.63473515 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.41054943 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.24960029 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.22585221 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.18349061 |
| 13 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.12068704 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.06500247 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.04375593 |
| 16 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.00692211 |
| 17 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.85226575 |
| 18 | * MYB_26560356_Chip-Seq_TH2_Human | 2.54423691 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 2.49293941 |
| 20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.44717528 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.42928572 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.36443030 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.34103406 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.33462177 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.32577324 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.30551008 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.26390913 |
| 28 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.22261071 |
| 29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.20616927 |
| 30 | * MYB_26560356_Chip-Seq_TH1_Human | 2.16721832 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.13726535 |
| 32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.07523987 |
| 33 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.03197350 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.02415372 |
| 35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.98224641 |
| 36 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.90030748 |
| 37 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.89794848 |
| 38 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82007990 |
| 39 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.73859124 |
| 40 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.69598511 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66100972 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.64363025 |
| 43 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.63005393 |
| 44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.58084567 |
| 45 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.57926888 |
| 46 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.55638480 |
| 47 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.49051915 |
| 48 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47933486 |
| 49 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.44956116 |
| 50 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43322216 |
| 51 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.41941188 |
| 52 | * MAF_26560356_Chip-Seq_TH2_Human | 1.41897850 |
| 53 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.41308133 |
| 54 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.41129052 |
| 55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39601921 |
| 56 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37007052 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34724430 |
| 58 | GATA3_26560356_Chip-Seq_TH2_Human | 1.25124885 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.23694786 |
| 60 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.23240553 |
| 61 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.18801858 |
| 62 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17748851 |
| 63 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.15109604 |
| 64 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.14390553 |
| 65 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14387753 |
| 66 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.13875271 |
| 67 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13305304 |
| 68 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11850767 |
| 69 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10965048 |
| 70 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.09088889 |
| 71 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08958334 |
| 72 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.08313065 |
| 73 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07918969 |
| 74 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07507256 |
| 75 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07378525 |
| 76 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.06713907 |
| 77 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05002831 |
| 78 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.03818023 |
| 79 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.03673488 |
| 80 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03651412 |
| 81 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02445743 |
| 82 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01873252 |
| 83 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99588380 |
| 84 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98399794 |
| 85 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96676226 |
| 86 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95244226 |
| 87 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.92301273 |
| 88 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92059797 |
| 89 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91967067 |
| 90 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.91095610 |
| 91 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.90763639 |
| 92 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90276943 |
| 93 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90252659 |
| 94 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89350897 |
| 95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88760882 |
| 96 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.86806942 |
| 97 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.85223318 |
| 98 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.85148349 |
| 99 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.77643268 |
| 100 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.77353534 |
| 101 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.76299581 |
| 102 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.76029736 |
| 103 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.72488133 |
| 104 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.71648667 |
| 105 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.69643249 |
| 106 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.69640890 |
| 107 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.69430868 |
| 108 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.69211420 |
| 109 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.68135665 |
| 110 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.67170426 |
| 111 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.66880078 |
| 112 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66023287 |
| 113 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.65920067 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 0.65382691 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.57609440 |
| 2 | MP0003436_decreased_susceptibility_to | 3.52625255 |
| 3 | MP0005671_abnormal_response_to | 3.41131453 |
| 4 | MP0009785_altered_susceptibility_to | 3.28753032 |
| 5 | MP0000685_abnormal_immune_system | 3.25363822 |
| 6 | MP0003303_peritoneal_inflammation | 3.17282883 |
| 7 | MP0001800_abnormal_humoral_immune | 3.13429979 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.11738604 |
| 9 | MP0001790_abnormal_immune_system | 3.11336166 |
| 10 | MP0005387_immune_system_phenotype | 3.11336166 |
| 11 | * MP0002452_abnormal_antigen_presenting | 2.84926499 |
| 12 | * MP0002419_abnormal_innate_immunity | 2.81401132 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.80067481 |
| 14 | * MP0005025_abnormal_response_to | 2.79179014 |
| 15 | * MP0002723_abnormal_immune_serum | 2.71744858 |
| 16 | * MP0002420_abnormal_adaptive_immunity | 2.64625948 |
| 17 | * MP0001819_abnormal_immune_cell | 2.63517579 |
| 18 | MP0006082_CNS_inflammation | 2.56180641 |
| 19 | MP0003763_abnormal_thymus_physiology | 2.55946560 |
| 20 | MP0002405_respiratory_system_inflammati | 2.30019303 |
| 21 | MP0003724_increased_susceptibility_to | 2.29840903 |
| 22 | MP0002398_abnormal_bone_marrow | 2.29284772 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.18112730 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.16381233 |
| 25 | MP0000716_abnormal_immune_system | 2.14966903 |
| 26 | MP0002166_altered_tumor_susceptibility | 2.12805409 |
| 27 | MP0002396_abnormal_hematopoietic_system | 2.08642360 |
| 28 | MP0001853_heart_inflammation | 2.05264481 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.95046027 |
| 30 | MP0000689_abnormal_spleen_morphology | 1.94712397 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.91975880 |
| 32 | MP0004510_myositis | 1.89024703 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.88844441 |
| 34 | MP0002006_tumorigenesis | 1.86577488 |
| 35 | MP0005058_abnormal_lysosome_morphology | 1.86309539 |
| 36 | MP0002722_abnormal_immune_system | 1.83431654 |
| 37 | MP0002429_abnormal_blood_cell | 1.78949177 |
| 38 | MP0004947_skin_inflammation | 1.78340889 |
| 39 | MP0001873_stomach_inflammation | 1.74082335 |
| 40 | MP0001533_abnormal_skeleton_physiology | 1.70591728 |
| 41 | MP0005451_abnormal_body_composition | 1.69997467 |
| 42 | MP0009278_abnormal_bone_marrow | 1.69895982 |
| 43 | MP0003172_abnormal_lysosome_physiology | 1.60523258 |
| 44 | MP0005397_hematopoietic_system_phenotyp | 1.59107366 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.59107366 |
| 46 | MP0008260_abnormal_autophagy | 1.58933691 |
| 47 | MP0004808_abnormal_hematopoietic_stem | 1.58528251 |
| 48 | MP0005310_abnormal_salivary_gland | 1.53699202 |
| 49 | MP0008469_abnormal_protein_level | 1.48270540 |
| 50 | MP0000703_abnormal_thymus_morphology | 1.47730672 |
| 51 | MP0003448_altered_tumor_morphology | 1.47127411 |
| 52 | MP0000465_gastrointestinal_hemorrhage | 1.46153341 |
| 53 | MP0000858_altered_metastatic_potential | 1.43197654 |
| 54 | MP0002933_joint_inflammation | 1.42990362 |
| 55 | MP0003183_abnormal_peptide_metabolism | 1.41301136 |
| 56 | MP0003866_abnormal_defecation | 1.36155672 |
| 57 | MP0009764_decreased_sensitivity_to | 1.28698456 |
| 58 | MP0004381_abnormal_hair_follicle | 1.28416420 |
| 59 | MP0005174_abnormal_tail_pigmentation | 1.25301369 |
| 60 | MP0000343_altered_response_to | 1.23977017 |
| 61 | MP0000569_abnormal_digit_pigmentation | 1.21061574 |
| 62 | MP0000490_abnormal_crypts_of | 1.19452017 |
| 63 | MP0003191_abnormal_cellular_cholesterol | 1.14183618 |
| 64 | MP0010307_abnormal_tumor_latency | 1.13998163 |
| 65 | MP0004883_abnormal_blood_vessel | 1.09197632 |
| 66 | MP0002009_preneoplasia | 1.06623404 |
| 67 | MP0001851_eye_inflammation | 1.01419009 |
| 68 | MP0000604_amyloidosis | 0.96356012 |
| 69 | MP0008057_abnormal_DNA_replication | 0.94035111 |
| 70 | MP0002998_abnormal_bone_remodeling | 0.93611026 |
| 71 | MP0003075_altered_response_to | 0.92679018 |
| 72 | MP0005076_abnormal_cell_differentiation | 0.92488261 |
| 73 | MP0010352_gastrointestinal_tract_polyps | 0.92009684 |
| 74 | MP0002019_abnormal_tumor_incidence | 0.89879787 |
| 75 | MP0003690_abnormal_glial_cell | 0.89393906 |
| 76 | MP0009840_abnormal_foam_cell | 0.89358318 |
| 77 | MP0009763_increased_sensitivity_to | 0.87335621 |
| 78 | MP0005166_decreased_susceptibility_to | 0.85677889 |
| 79 | MP0002138_abnormal_hepatobiliary_system | 0.77654329 |
| 80 | MP0003828_pulmonary_edema | 0.77524088 |
| 81 | MP0000015_abnormal_ear_pigmentation | 0.75449397 |
| 82 | MP0003045_fibrosis | 0.75369927 |
| 83 | MP0003566_abnormal_cell_adhesion | 0.73358587 |
| 84 | MP0002277_abnormal_respiratory_mucosa | 0.72011000 |
| 85 | MP0005390_skeleton_phenotype | 0.69745908 |
| 86 | MP0003221_abnormal_cardiomyocyte_apopto | 0.69268810 |
| 87 | MP0005023_abnormal_wound_healing | 0.69225289 |
| 88 | MP0000249_abnormal_blood_vessel | 0.65618744 |
| 89 | MP0003693_abnormal_embryo_hatching | 0.65261015 |
| 90 | MP0001663_abnormal_digestive_system | 0.64755085 |
| 91 | MP0005075_abnormal_melanosome_morpholog | 0.64498390 |
| 92 | MP0003806_abnormal_nucleotide_metabolis | 0.64287621 |
| 93 | MP0002132_abnormal_respiratory_system | 0.61193118 |
| 94 | MP0000371_diluted_coat_color | 0.60470414 |
| 95 | MP0003795_abnormal_bone_structure | 0.60230432 |
| 96 | MP0002877_abnormal_melanocyte_morpholog | 0.59865553 |
| 97 | MP0004782_abnormal_surfactant_physiolog | 0.59811689 |
| 98 | MP0008874_decreased_physiological_sensi | 0.56858375 |
| 99 | MP0003077_abnormal_cell_cycle | 0.56524476 |
| 100 | MP0002136_abnormal_kidney_physiology | 0.55755994 |
| 101 | MP0010094_abnormal_chromosome_stability | 0.55620595 |
| 102 | MP0000609_abnormal_liver_physiology | 0.54926243 |
| 103 | MP0008004_abnormal_stomach_pH | 0.54478711 |
| 104 | MP0003091_abnormal_cell_migration | 0.53757942 |
| 105 | MP0003656_abnormal_erythrocyte_physiolo | 0.53695199 |
| 106 | MP0009765_abnormal_xenobiotic_induced | 0.53623412 |
| 107 | MP0002095_abnormal_skin_pigmentation | 0.51351493 |
| 108 | MP0003453_abnormal_keratinocyte_physiol | 0.50318284 |
| 109 | MP0000313_abnormal_cell_death | 0.50110355 |
| 110 | MP0008873_increased_physiological_sensi | 0.49790373 |
| 111 | MP0002693_abnormal_pancreas_physiology | 0.49195577 |
| 112 | MP0000598_abnormal_liver_morphology | 0.47946808 |
| 113 | MP0009115_abnormal_fat_cell | 0.45890727 |
| 114 | MP0005164_abnormal_response_to | 0.44193955 |
| 115 | MP0001986_abnormal_taste_sensitivity | 0.42835165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.21153067 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.16965458 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.47938347 |
| 4 | Myositis (HP:0100614) | 4.64969485 |
| 5 | Recurrent fungal infections (HP:0002841) | 4.51073225 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.50317482 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.50138288 |
| 8 | Recurrent viral infections (HP:0004429) | 4.15145152 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 4.15034741 |
| 10 | Chronic otitis media (HP:0000389) | 4.01784994 |
| 11 | Abnormality of macrophages (HP:0004311) | 3.98403420 |
| 12 | Stomatitis (HP:0010280) | 3.97592239 |
| 13 | Obstructive lung disease (HP:0006536) | 3.90494649 |
| 14 | Chronic obstructive pulmonary disease (HP:0006510) | 3.90494649 |
| 15 | Recurrent skin infections (HP:0001581) | 3.88693045 |
| 16 | IgM deficiency (HP:0002850) | 3.87203023 |
| 17 | Orchitis (HP:0100796) | 3.79939464 |
| 18 | Optic neuritis (HP:0100653) | 3.76386026 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 3.76386026 |
| 20 | Vasculitis (HP:0002633) | 3.62974191 |
| 21 | Meningitis (HP:0001287) | 3.61918614 |
| 22 | Recurrent bronchitis (HP:0002837) | 3.58651358 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.55387945 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.55387945 |
| 25 | Abnormality of T cell number (HP:0011839) | 3.44853167 |
| 26 | T lymphocytopenia (HP:0005403) | 3.40049430 |
| 27 | Cellulitis (HP:0100658) | 3.39554524 |
| 28 | Autoimmune thrombocytopenia (HP:0001973) | 3.36506923 |
| 29 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.34147397 |
| 30 | Gingivitis (HP:0000230) | 3.28390091 |
| 31 | Abnormality of T cells (HP:0002843) | 3.25799331 |
| 32 | Vacuolated lymphocytes (HP:0001922) | 3.11600134 |
| 33 | Pustule (HP:0200039) | 3.06783391 |
| 34 | Panhypogammaglobulinemia (HP:0003139) | 3.06526327 |
| 35 | Increased cerebral lipofuscin (HP:0011813) | 3.04212035 |
| 36 | Spontaneous hematomas (HP:0007420) | 3.02788308 |
| 37 | Abnormality of T cell physiology (HP:0011840) | 3.00950358 |
| 38 | Inflammation of the large intestine (HP:0002037) | 3.00498995 |
| 39 | Thrombocytosis (HP:0001894) | 2.99103337 |
| 40 | Nasal polyposis (HP:0100582) | 2.97479495 |
| 41 | Agammaglobulinemia (HP:0004432) | 2.94220440 |
| 42 | Pulmonary infiltrates (HP:0002113) | 2.93984511 |
| 43 | Periodontitis (HP:0000704) | 2.90863627 |
| 44 | Lymphopenia (HP:0001888) | 2.89754144 |
| 45 | Gastrointestinal inflammation (HP:0004386) | 2.88817073 |
| 46 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.87585421 |
| 47 | Autoimmune hemolytic anemia (HP:0001890) | 2.86876316 |
| 48 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.86046469 |
| 49 | Interstitial pulmonary disease (HP:0006530) | 2.84384088 |
| 50 | Arterial thrombosis (HP:0004420) | 2.83496462 |
| 51 | Leukocytosis (HP:0001974) | 2.78857714 |
| 52 | Colitis (HP:0002583) | 2.76069920 |
| 53 | Gastrointestinal stroma tumor (HP:0100723) | 2.73116210 |
| 54 | Keratoconjunctivitis sicca (HP:0001097) | 2.68928444 |
| 55 | Eosinophilia (HP:0001880) | 2.67928269 |
| 56 | Hemoptysis (HP:0002105) | 2.66216607 |
| 57 | Osteomyelitis (HP:0002754) | 2.65631659 |
| 58 | Abnormality of the nasal mucosa (HP:0000433) | 2.64537996 |
| 59 | IgA deficiency (HP:0002720) | 2.62665074 |
| 60 | IgG deficiency (HP:0004315) | 2.60329691 |
| 61 | Encephalitis (HP:0002383) | 2.58502247 |
| 62 | Pulmonary embolism (HP:0002204) | 2.56821964 |
| 63 | Chronic diarrhea (HP:0002028) | 2.52624461 |
| 64 | Recurrent sinusitis (HP:0011108) | 2.51595805 |
| 65 | Keratoconjunctivitis (HP:0001096) | 2.50704715 |
| 66 | Recurrent pneumonia (HP:0006532) | 2.50358476 |
| 67 | Petechiae (HP:0000967) | 2.50197168 |
| 68 | Urticaria (HP:0001025) | 2.48619406 |
| 69 | Systemic lupus erythematosus (HP:0002725) | 2.47956037 |
| 70 | Abnormality of the prostate (HP:0008775) | 2.46940116 |
| 71 | Granulocytopenia (HP:0001913) | 2.46923377 |
| 72 | Anorexia (HP:0002039) | 2.45621332 |
| 73 | Gangrene (HP:0100758) | 2.44506857 |
| 74 | Thyroiditis (HP:0100646) | 2.42375404 |
| 75 | Severe combined immunodeficiency (HP:0004430) | 2.42167381 |
| 76 | Abnormality of eosinophils (HP:0001879) | 2.41914940 |
| 77 | Combined immunodeficiency (HP:0005387) | 2.41104527 |
| 78 | Increased IgM level (HP:0003496) | 2.36686792 |
| 79 | Increased IgE level (HP:0003212) | 2.36470891 |
| 80 | Gingival bleeding (HP:0000225) | 2.34823244 |
| 81 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.34789829 |
| 82 | Viral hepatitis (HP:0006562) | 2.34668300 |
| 83 | B lymphocytopenia (HP:0010976) | 2.33395741 |
| 84 | Abnormality of B cell number (HP:0010975) | 2.33395741 |
| 85 | Hypergammaglobulinemia (HP:0010702) | 2.32003241 |
| 86 | Chest pain (HP:0100749) | 2.31888041 |
| 87 | Recurrent lower respiratory tract infections (HP:0002783) | 2.29576325 |
| 88 | Epistaxis (HP:0000421) | 2.25798186 |
| 89 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.25586284 |
| 90 | Emphysema (HP:0002097) | 2.22672307 |
| 91 | Amaurosis fugax (HP:0100576) | 2.21992552 |
| 92 | Gastrointestinal infarctions (HP:0005244) | 2.21465819 |
| 93 | Verrucae (HP:0200043) | 2.20319336 |
| 94 | Papilloma (HP:0012740) | 2.20319336 |
| 95 | Basal ganglia calcification (HP:0002135) | 2.18722689 |
| 96 | Skin ulcer (HP:0200042) | 2.18356337 |
| 97 | Hypochromic anemia (HP:0001931) | 2.17578963 |
| 98 | Lymphoma (HP:0002665) | 2.17383134 |
| 99 | Hematochezia (HP:0002573) | 2.17189142 |
| 100 | Joint swelling (HP:0001386) | 2.16643210 |
| 101 | Abnormality of the fingertips (HP:0001211) | 2.16201395 |
| 102 | Dysostosis multiplex (HP:0000943) | 2.15905770 |
| 103 | Prolonged bleeding time (HP:0003010) | 2.15828940 |
| 104 | Episodic fever (HP:0001954) | 2.14607688 |
| 105 | Glomerulopathy (HP:0100820) | 2.14171869 |
| 106 | Acute hepatic failure (HP:0006554) | 2.09427268 |
| 107 | Skin rash (HP:0000988) | 2.08803302 |
| 108 | Chronic sinusitis (HP:0011109) | 2.08027726 |
| 109 | Restrictive lung disease (HP:0002091) | 2.06671971 |
| 110 | Abnormality of the peritoneum (HP:0002585) | 2.06296505 |
| 111 | Myocardial infarction (HP:0001658) | 2.04749488 |
| 112 | Slow saccadic eye movements (HP:0000514) | 2.03840295 |
| 113 | Amyloidosis (HP:0011034) | 2.02406087 |
| 114 | Abnormality of the pleura (HP:0002103) | 2.02047637 |
| 115 | Sepsis (HP:0100806) | 2.01405700 |
| 116 | Hepatosplenomegaly (HP:0001433) | 2.00925863 |
| 117 | Abnormality of glycolipid metabolism (HP:0010969) | 2.00758706 |
| 118 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.00758706 |
| 119 | Abnormality of the endocardium (HP:0004306) | 1.98790109 |
| 120 | Polyneuropathy (HP:0001271) | 1.98425950 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.11145468 |
| 2 | TXK | 3.60114168 |
| 3 | MAP3K14 | 2.98745823 |
| 4 | BLK | 2.96720942 |
| 5 | IRAK4 | 2.93703963 |
| 6 | TYK2 | 2.83341336 |
| 7 | PRPF4B | 2.78930874 |
| 8 | JAK3 | 2.76575192 |
| 9 | ZAP70 | 2.52287403 |
| 10 | TBK1 | 2.44634417 |
| 11 | KIT | 2.37849656 |
| 12 | STK10 | 2.35766603 |
| 13 | BTK | 2.17347402 |
| 14 | ITK | 2.11368116 |
| 15 | IKBKE | 2.09753817 |
| 16 | TEC | 2.03832969 |
| 17 | RIPK4 | 2.03553762 |
| 18 | SYK | 1.93521627 |
| 19 | JAK1 | 1.91814769 |
| 20 | CSF1R | 1.85436379 |
| 21 | IKBKB | 1.79198441 |
| 22 | CSK | 1.76536028 |
| 23 | IRAK3 | 1.72475519 |
| 24 | HCK | 1.62860242 |
| 25 | ERN1 | 1.60537229 |
| 26 | LCK | 1.55804889 |
| 27 | MAP2K3 | 1.54638870 |
| 28 | FES | 1.53448939 |
| 29 | EPHB1 | 1.50599746 |
| 30 | FGFR4 | 1.46105416 |
| 31 | GRK6 | 1.43846198 |
| 32 | BMPR2 | 1.39682504 |
| 33 | TAOK3 | 1.38986812 |
| 34 | LRRK2 | 1.31828621 |
| 35 | MAP3K13 | 1.31680630 |
| 36 | LYN | 1.28930432 |
| 37 | CLK1 | 1.28303527 |
| 38 | FGFR3 | 1.27348321 |
| 39 | TGFBR2 | 1.26729925 |
| 40 | PIM1 | 1.13047458 |
| 41 | CHUK | 1.12304556 |
| 42 | RPS6KA4 | 1.07220954 |
| 43 | MAP3K1 | 1.05272550 |
| 44 | EEF2K | 1.04509031 |
| 45 | SMG1 | 1.04136220 |
| 46 | KSR2 | 1.02546953 |
| 47 | TESK2 | 0.99530419 |
| 48 | JAK2 | 0.97599141 |
| 49 | PIM2 | 0.96797573 |
| 50 | NEK9 | 0.94197635 |
| 51 | MARK3 | 0.92919659 |
| 52 | PIK3CG | 0.92856822 |
| 53 | YES1 | 0.90786225 |
| 54 | KDR | 0.88859050 |
| 55 | MST4 | 0.87132554 |
| 56 | TAOK2 | 0.85606856 |
| 57 | PRKCQ | 0.82987082 |
| 58 | MAP3K10 | 0.82332730 |
| 59 | NME2 | 0.80680805 |
| 60 | TRIB3 | 0.80578011 |
| 61 | NLK | 0.79075364 |
| 62 | TRPM7 | 0.77447547 |
| 63 | SIK2 | 0.77012229 |
| 64 | PKN2 | 0.75836726 |
| 65 | EPHA3 | 0.73647937 |
| 66 | STK4 | 0.69602482 |
| 67 | FLT3 | 0.69394197 |
| 68 | FGR | 0.66824689 |
| 69 | CAMKK2 | 0.66311286 |
| 70 | MAPK12 | 0.66238091 |
| 71 | IRAK2 | 0.64690614 |
| 72 | CDK12 | 0.60043338 |
| 73 | TTN | 0.59877601 |
| 74 | MATK | 0.59162570 |
| 75 | PDPK1 | 0.58984280 |
| 76 | MAPK7 | 0.57404294 |
| 77 | MAP3K11 | 0.56717400 |
| 78 | CDK4 | 0.55092957 |
| 79 | MARK2 | 0.55074222 |
| 80 | SIK3 | 0.54518033 |
| 81 | MAP3K8 | 0.53629771 |
| 82 | GRK7 | 0.53058309 |
| 83 | MAP3K3 | 0.52316960 |
| 84 | PTK6 | 0.52248329 |
| 85 | PRKCH | 0.50844235 |
| 86 | HIPK2 | 0.50058691 |
| 87 | CDK19 | 0.48860709 |
| 88 | CAMKK1 | 0.48787554 |
| 89 | RAF1 | 0.48633462 |
| 90 | MAPKAPK2 | 0.48527379 |
| 91 | CDC42BPA | 0.47380524 |
| 92 | ALK | 0.47343203 |
| 93 | ABL1 | 0.46757919 |
| 94 | CDK6 | 0.46727352 |
| 95 | EGFR | 0.46591826 |
| 96 | MAP3K2 | 0.46131693 |
| 97 | NEK2 | 0.45347832 |
| 98 | MAP3K6 | 0.43964844 |
| 99 | TGFBR1 | 0.43054091 |
| 100 | MAP3K12 | 0.42875621 |
| 101 | SCYL2 | 0.40615007 |
| 102 | SGK3 | 0.39978100 |
| 103 | PDK1 | 0.39439649 |
| 104 | MAP3K5 | 0.39068168 |
| 105 | TAOK1 | 0.38655379 |
| 106 | TNK2 | 0.37821937 |
| 107 | IRAK1 | 0.36753111 |
| 108 | * PRKCD | 0.36398094 |
| 109 | RPS6KA6 | 0.36271689 |
| 110 | PASK | 0.35306418 |
| 111 | MAPK4 | 0.33819613 |
| 112 | CAMK1D | 0.33025658 |
| 113 | FYN | 0.32692835 |
| 114 | PAK4 | 0.31169302 |
| 115 | RET | 0.30818830 |
| 116 | MAP2K6 | 0.30705326 |
| 117 | TESK1 | 0.30681926 |
| 118 | MAP3K7 | 0.30309149 |
| 119 | PRKD2 | 0.30302839 |
| 120 | ACVR1B | 0.28351732 |
| 121 | IGF1R | 0.27782957 |
| 122 | MAPK11 | 0.25733498 |
| 123 | ATR | 0.25699293 |
| 124 | RPS6KL1 | 0.24151575 |
| 125 | RPS6KC1 | 0.24151575 |
| 126 | CDC7 | 0.23685898 |
| 127 | STK24 | 0.22193676 |
| 128 | EIF2AK2 | 0.21944069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.28602746 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.16515392 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.69431726 |
| 4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.60794470 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.50885317 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.47830489 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.46942419 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.44460041 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.43219654 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.41857853 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.28104860 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.20007106 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.19388865 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.15975943 |
| 15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.97352994 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.94064897 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.84983048 |
| 18 | Legionellosis_Homo sapiens_hsa05134 | 1.83544179 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.80562072 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.77240220 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.75564341 |
| 22 | Pertussis_Homo sapiens_hsa05133 | 1.75085253 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.68984677 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.67044203 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.64578294 |
| 26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.61698123 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.60710602 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.58568810 |
| 29 | Shigellosis_Homo sapiens_hsa05131 | 1.53849686 |
| 30 | Malaria_Homo sapiens_hsa05144 | 1.53132063 |
| 31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.50080609 |
| 32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.48906774 |
| 33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.46482737 |
| 34 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.44407533 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.44258246 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.42621989 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.40150776 |
| 38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.34930177 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.34329495 |
| 40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.30857244 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 1.27174717 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.25417949 |
| 43 | Lysosome_Homo sapiens_hsa04142 | 1.23573405 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 1.23157669 |
| 45 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.22210682 |
| 46 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.15585136 |
| 47 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.09274821 |
| 48 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.02238328 |
| 49 | DNA replication_Homo sapiens_hsa03030 | 0.98941314 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.96794708 |
| 51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.96425227 |
| 52 | Phagosome_Homo sapiens_hsa04145 | 0.93530338 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.93300279 |
| 54 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.92592689 |
| 55 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.90579905 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.88390352 |
| 57 | Base excision repair_Homo sapiens_hsa03410 | 0.83910174 |
| 58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83692959 |
| 59 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.81135652 |
| 60 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79939397 |
| 61 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.79102847 |
| 62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.77441068 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71638166 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71461120 |
| 65 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71045421 |
| 66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67616440 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67335370 |
| 68 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.66051564 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56815531 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56280240 |
| 71 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54654409 |
| 72 | Mismatch repair_Homo sapiens_hsa03430 | 0.52688997 |
| 73 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.52318363 |
| 74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50832640 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.50415741 |
| 76 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43936316 |
| 77 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.43704384 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43641167 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42922297 |
| 80 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42795452 |
| 81 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41747697 |
| 82 | Amoebiasis_Homo sapiens_hsa05146 | 0.41447865 |
| 83 | Endocytosis_Homo sapiens_hsa04144 | 0.40891931 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39670136 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39366070 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.38909858 |
| 87 | Colorectal cancer_Homo sapiens_hsa05210 | 0.38127886 |
| 88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.37504276 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.35127288 |
| 90 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.34998640 |
| 91 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.34097418 |
| 92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.33828584 |
| 93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.33620998 |
| 94 | Homologous recombination_Homo sapiens_hsa03440 | 0.32280798 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31511735 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30866442 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30736779 |
| 98 | Insulin resistance_Homo sapiens_hsa04931 | 0.27657983 |
| 99 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.26969497 |
| 100 | Glioma_Homo sapiens_hsa05214 | 0.26293162 |
| 101 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.25913227 |
| 102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.25179784 |
| 103 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.25147964 |
| 104 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.24369010 |
| 105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.23446376 |
| 106 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.23403786 |
| 107 | Bladder cancer_Homo sapiens_hsa05219 | 0.21174444 |
| 108 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.19960069 |
| 109 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.19771578 |
| 110 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.18314911 |
| 111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.17989106 |
| 112 | Cell cycle_Homo sapiens_hsa04110 | 0.16388104 |
| 113 | Prostate cancer_Homo sapiens_hsa05215 | 0.15623438 |
| 114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.15573500 |
| 115 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.15201126 |
| 116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.15067887 |

